Ardilouze 2015.

Trial name or title	Glycemic objectives of women with GDM.
Methods	Randomised controlled trial. Unblinded. Canada.
Participants	30 women, 15‐32 weeks' gestation. Excluded: known type 1 or type 2 diabetes, treatment interfering with glucose metabolism.
Interventions	Normal glycaemic control target: fasting: 5.3 mmol/L (95 mg/dL) and 2‐hour after meals: 6.7 mmol/L (120 mg/dL). Using diet, physical exercise or insulin to reach normal glycaemic control. Low glycaemic control target: fasting: 4.8 mmol/L ( 86 mg/dL) and 2‐hour after meals: 5.9 mmol/L (106 mg/dL). Using diet, physical exercise or insulin to reach low glycaemic control.
Outcomes	Primary outcome: fetal glycated haemoglobin at delivery. Secondary outcome: treatment satisfaction.
Starting date	March 2015.
Contact information	Jean‐Luc Ardilouze: Jean‐Luc.Ardilouze@USherbrooke.ca Julie Menard: jumenard.chus@ssss.gouv.qc.ca
Notes	Clinical Trial Identifier: NCT02478762.